L

Leben Salud | Fundacion Medica de Rio Negro y Neuquen

Research site
(Unclaimed)
Location
47 Irigoyen Street, Cipolletti, Rio Negro, Argentina

Site insights

Top conditions

Top treatments

Bemarituzumab

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

1 of 1 total trial

A Study Evaluating Bemarituzumab in Solid Tumors With Fibroblast Growth Factor Receptor 2b (FGFR2b) Overexpression (FORTITUDE-301)

The primary objectives of this study are to observe the safety and tolerability of bemarituzumab and to evaluate preliminary antitumor activity.

Enrolling
Solid Tumors
Drug: Bemarituzumab

Trial sponsors

Amgen logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems